1. Home
  2. RLAY vs MATH Comparison

RLAY vs MATH Comparison

Compare RLAY & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

SELL

Current Price

$17.29

Market Cap

3.8B

Sector

Health Care

ML Signal

SELL

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

SELL

Current Price

$1.04

Market Cap

49.9M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RLAY
MATH
Founded
2015
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
49.9M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
RLAY
MATH
Price
$17.29
$1.04
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $28.25
N/A
AVG Volume (30 Days)
★ 2.4M
29.1K
Earning Date
11-04-2026
08-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.78
N/A
EPS
N/A
★ N/A
Revenue
★ $15,355,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$63.45
N/A
P/E Ratio
★ N/A
$3.10
Revenue Growth
★ 53.44
N/A
52 Week Low
$6.25
$0.73
52 Week High
$21.27
$3.19

Technical Indicators

Market Signals
Indicator
RLAY
MATH
Relative Strength Index (RSI) 44.31 52.88
Support Level $17.33 $0.93
Resistance Level $17.40 $1.13
Average True Range (ATR) 1.24 0.09
MACD -0.05 -0.00
Stochastic Oscillator 19.14 60.26

Price Performance

Historical Comparison
RLAY
MATH

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd mainly operates in the trading of proprietary digital assets and derivative contracts in Hong Kong. The Company's primary business operations center on digital asset services, offered through its subsidiaries. The Company generates income mainly from executing cryptocurrency-related transactions, including providing derivative solutions to over-the-counter (OTC) clients, issuing derivative products to OTC clients, and engaging in proprietary trading activities. The Company provides crypto derivative solutions and liquidity to its clients, facilitated through its principal trading activities, enabling seamless trading of crypto derivative solutions. The Company generates revenue from Hong Kong.

Share on Social Networks: